Predicting Alzheimer's disease using combined imaging-whole genome SNP data

Journal of Alzheimer's Disease

Volumn 46, Issue 3, 2015, Pages 695-702

  Kong, Dehan ^a   Giovanello, Kelly S ^b,c   Wang, Yalin ^d   Lin, Weili ^c   Lee, Eunjee ^b   Fan, Yong ^e   Murali Doraiswamy, P ^f   Zhu, Hongtu ^a,c  

^a IL   (United States)

^b University of North Carolina at Chapel Hill   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d ARIZONA STATE UNIVERSITY   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; genetics; magnetic resonance imaging; proportional hazards models; risk

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ANTERIOR COMMISSURE; ARTICLE; BRAIN REGION; COGNITION; DISEASE COURSE; FEMALE; GENETIC ASSOCIATION; HIPPOCAMPUS; HUMAN; IMAGE PROCESSING; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PRIORITY JOURNAL; REGISTRATION; SINGLE NUCLEOTIDE POLYMORPHISM; WHITE MATTER; COGNITIVE DYSFUNCTION; COMPLICATION; GENETIC ASSOCIATION STUDY; GENETICS; GENOME; PATHOLOGY; PRINCIPAL COMPONENT ANALYSIS; PSYCHOLOGICAL RATING SCALE; VERY ELDERLY;

APOLIPOPROTEIN E4;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; COGNITIVE DYSFUNCTION; FEMALE; GENETIC ASSOCIATION STUDIES; GENOME; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PRINCIPAL COMPONENT ANALYSIS; PSYCHIATRIC STATUS RATING SCALES;

EID: 84934271687     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-150164     Document Type: Article

References (42)

1. Weiner MW, Veitcha DP, Aisen PS, Beckett LA, Cairnsh NJ, Green RC, Harvey D, Jack CR, Jagust W, Liu E, Morris JC, Petersen RC, Saykino AJ, Schmidt ME, Shaw L, Siuciak JA, Soares H, Toga AW, Trojanowski JQ, Alzheimer's Disease Neuroimaging, Initiative (2012) The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception. Alzheimers Dement 8, S1-S68.
2. Doraiswamy PM, Sperling RA, Johnson K, Reiman EM, Wong TZ, Sabbagh MN, Sadowsky CH, Fleisher AS, Carpenter A, Joshi AD, Lu M, Grundman M, Mintun MA, Skovronsky DM, Pontecorvo MJ, AV45-A11 Study, Group (2014) Florbetapir F 18 amyloid PET and 36-month cognitive decline: A prospective multicenter study. Mol Psychiatry 19, 1044-1051.
3. Atluri G, Padmanabhan K, Fang G, Steinbach M, Petrella JR, Lim K, Macdonald A, 3rd, Samatova NF, Doraiswamy PM, Kumar V (2013) Complex biomarker discovery in neuroimag-ing data: Finding a needle in a haystack. Neuroimage Clin 3, 123-131.
4. Costafreda SG, Dinov ID, Tu Z, Shi Y, Liu CY, Kloszewska 1, Mecocci P, Soininen H, Tsolaki M, Vellas B, Wahlund LO, Spenger C, Toga AW, Lovestone S, Simmons A (2011) Automated hippocampal shape analysis predicts the onset of dementia in mild cognitive impairment. Neuroimage 56, 212-219.
5. Cui Y, Liu B, Luo S, Zhen X, Fan M, Liu T, Zhu W, Park, Jiang M, Jin T, SE (2011) Identification of conversion from mild cognitive impairment to Alzheimer's disease using multivariate predictors. PLoS One 6, e21896.
6. Cuingnet R, Gerardin E, Tessieras J, Auzias G, Lehericy S, Habert MO, Chupin M, Benali H, Colliot O (2011) Automatic classification of patients with Alzheimer's disease from structural MRI: A comparison often methods using the ADNI database. Neuroimage 56, 766-781.
7. Davatzikos C, Bhatt P, Shaw LM, Batmanghelich KN, Tro-janowski JQ (2011) Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification. Neurobiol Aging 32, 2322.e19-2322.e27.
8. Dickerson BC, Wolk DA (2013) Alzheimer's Disease Neuroimaging Initiative. Biomarker-based prediction of progression in MCI: Comparison of AD signature and hippocampal volume with spinal fluid amyloid-fj and tau. Front Aging Neurosci 5, 1-9.
9. Eckerstrom C, Olsson E, Bjerke M, Malmgren H, Edman A, Wallin A, Nordlund A (2013) A combination of neuropsychological, neuroimaging, and cerebrospinal fluid markers predicts conversion from mild cognitive impairment to dementia. J Alzheimers Dis 36, 421-431.
10. Jack CR Jr, Petersen RC, Xu YC, O'Brien PC, Smith GE, Ivnik RJ, Boeve BF, Waring SC, Tangalos EG, Kokmen E (1999) Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 52, 1397-1403.
11. Qiu A, Fennema-Notestine C, Dale AM, Miller MI (2009) Regional shape abnormalities in mild cognitive impairment and Alzheimer's disease. Neuroimage 45, 656-661.
12. Querbes O, Aubry F, Pariente J, Lotterie JA, Demonet JF, Duret V, Puel M, Berry I, Fort JC, Celsis P (2009) Early diagnosis of Alzheimer's disease using cortical thickness: Impact of cognitive reserve. Brain 132, 2036-2047.
13. Shaffe JL, Petrella JR, Sheldon FC, Choudhury KR, Calhoun VD, Coleman RE, Doraiswamy PM, Alzheimer's Disease Neuroimaging, Initiative (2013) Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined cerebrospinal fluid, MR imaging, and PET biomarkers. Radiology 266, 583-591.
14. Toledo JB, Weiner MW, Wolk DA, Da X, Chen K, Arnold SE, Jagust W, Jack C, Reiman EM, Davatzikos C, Shaw LM, Tro-janowski JQ, Alzheimer's Disease Neuroimaging, Initiative (2014) Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition. Acta Neuropathol Commun 2, 26.
15. Young J, Modat M, Cardoso MJ, Mendelson A, Cash D, Ourselin S (2013) Accurate multimodal probabilistic prediction of conversion to Alzheimer's disease in patients with mild cognitive impairment. Neuroimage Clin 2, 735-745.
16. Zhang D, Shen D (2012) Predicting future clinical changes of MCI patients using longitudinal and multimodal biomarkers. PLoS One 7, e33182.
17. Hohman TJ, Koran ME, Thornton-Wells TA, Alzheimer's Disease Neuroimaging, Initiative (2014) Genetic modification of the relationship between phosphorylated tau and neurodegeneration. Alzheimers Dement 10, 637-645.
18. Singh N, Wang AY, Sankaranarayanan P, Fletcher PT, Joshi S (2012) Genetic, structural and functional imaging biomarkers for early detectionofconversion from MCItoAD. Med Image Comput Comput Assist Interv 15, 132-140.
19. Lemoine B, Rayburn S, Benton R (2010) Data Fusion and Feature Selection for Alzheimer's Diagnosis. In: Yao Y, Sun R, Poggio T, Liu J, Zhong N, Huang J, eds. BI 2010. LNAI 6334, Springer-Verlag Berlin Heidelberg, pp. 320-327.
20. Shen DG, Davatzikos C (2004) Measuring temporal morphological changes robustly in brain MR images via 4-dimensional template warping.Neuroimage 21, 1508-1517.
21. Bryant C, Giovanello KS, Ibrahim JG, Chang J, Shen D, Peterson BS, Zhu HT, Alzheimer's Disease Neuroimaging, Initiative (2013) Mapping the genetic variation of regional brain volumes as explained by all common SNPs from the ADNI study. PloS One 8, e71723.
22. Wang Y, Song Y, Rajagopalan P, An T, Liu K, Chou Y-Y, Gutman B, Toga AW, Thompson PM (2011) Surface-based TBM boosts power to detect disease effects on the brain: An N=804 ADNI study. Neuroimage 56, 1993-2010.
23. Fennema-Notestine C, Hagler DJ, McEvoy LK, Fleisher AS, Wu EH, Karow DS, Dale AM (2009) Structural MRI biomarkers for preclinical and mild Alzheimer's disease. Hum Brain Mapp 30, 3238-3253.
24. Ryan NS, Keihaninejad S, Shakespeare TJ, Lehmann M, Crutch SJ, Malone IB, Thornton JS, Mancini L, Hyare H, Yousry T, Ridgway GR, Zhang H, Modat M, Alexander DC, Rossor MN, Ourselin S, Fox NC (2013) Magnetic resonance imaging evidence for presymptomatic change in thalamus and caudate in familial Alzheimer's disease. Brain 136, 1399-1414.
25. Shi J, Wang Y, Ceschin R, An X, Lao Y, Vanderbilt D, Nelson, MD, Thompson PM, Panigrahy A, Lepore N (2013) A mul-tivariate surface-based analysis of the putamen in premature newborns: Regional differences within the ventral striatum. PloS One 8, e66736.
26. Shi J, Thompson PM, Gutman B, Wang Y (2013) Surface fluid registration of conformal representation: Application to detect disease burden and genetic influence on hippocampus. Neuroimage 78, 111-134.
27. Shi J, Lepor N, Gutman BA, Thompson PM, Baxter LC, Caselli RL, Wang Y, Alzheimer's Disease Neuroimaging, Initiative (2014) Genetic influence of apolipoprotein E4 genotype on hippocampal morphometry: An N=725 surface-based Alzheimer's disease neuroimaging initiative study. Hum Brain Mapp 35, 3903-3018.
28. Monje M, Thomason ME, Rigolo L, Wang Y, Waber DP, Sal-lan SE, Golby AJ (2013) Functional and structural differences in the hippocampus associated with memory deficits in adult survivors of acute lymphoblastic leukemia. Pediatr Blood Cancer 60, 293-300.
29. Colom R, Stein JL, Rajagopalan P, Martinez K, Hermel D, Wang Y, Alvarez-Linera J, Burgaleta, M, Quiroga M, Shih PC, Thompson PM (2013) Hippocampal structure and human cognition: Key role of spatial processing and evidence supporting the efficiency hypothesis in females. Intelligence 41, 129-140.
30. Luders E, Thompson PM, Kurth F, Hong JY, Phillips OR, Wang Y, Gutman BA, Chou YY, Narr KL, Toga AW (2013) Global and regional alterations of hippocampal anatomy in long-term meditation practitioners. Hum Brain Mapp 34, 3369-3375.
31. Patenaude B, Smith SM, Kennedy DN, Jenkinson M (2011) A Bayesian model of shape and appearance for subcortical brain segmentation. Neuroimage 56, 907-922.
32. Lorensen WE, Cline HE (1987) Marching cubes: A high resolution 3D surface construction algorithm. ACM SIGGRAPH Comput Graph 21, 163-169.
33. Wang Y, Zhang J, Gutman B, Chan TF, Becker JT, Aizenstein HJ, Lopez OL, Tamburo RJ, Toga AW, Thompson PM (2010) Multivariate tensor-based morphometry on surfaces: Application to mapping ventricular abnormalities in HIV/AIDS. Neuroimage 49, 2141-2157.
34. Pizer SM, Fritsch DS, Yushkevich PA, Johnson VE, Chaney EL (1999) Segmentation, registration, and measurement of shape variation via image object shape. IEEE Trans Med Imaging 18, 851-865.
35. Liu X, Cai T, Wu MC, Zhou Q, Liu G, Christiani DC, Lin X (2011) Kernel machine SNP-set analysis for censored survival outcomes in genome-wide association studies. Genet Epidemiol 35, 620-631.
36. Rice JA, Silverman BW (1991) Estimating the mean and covariance structure nonparametrically when the data are curves. J R Stat Soc Series B Stat Methodol 53, 233-243.
37. Ramsay JO, Silverman BW. (2005)Functional Data Analysis, 2nd ed. Springer Series in Statistics, Springer, New York.
38. Champless LE, Diao G (2006) Estimation of time-dependent area under the curve for long-term risk prediction. Stat Med 25, 3474-3486.
39. Li H, Liu Y, Gong P, Zhang C, Ye J, Alzheimer's Disease Neuroimaging, Initiative (2014) Hierarchical interactions model for predicting mild cognitive impairment (MCI) to Alzheimer's disease (AD) conversion. PLoS One 9, e82450.
40. Wray NR, Yang J, Hayes BJ, Price AL, Goddard ME, Visscher PM (2013) Pitfalls of predicting complex traits from SNPs. Nat Rev Genet 14, 507-515.
41. Bagyinszky E, Youn YC, An SS, Kim S (2014) The genetics of Alzheimer's disease. Clin Interv Aging 9, 535-551.
42. Murphy KR, Landau SM, Choudhury KR, Hostage CA, Shpanskaya KS, Sair HI, Petrella JR, Wong TZ, Doraiswamy PM, Alzheimer's Disease Neuroimaging, Initiative (2013) Mapping the effects of ApoE4, age and cognitive status on 18F-florbetapir PET measured regional cortical patterns of beta-amyloid density and growth. Neuroimage 78, 474-480.